| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology [T. J., A. B., H. E. D., M. B.] and Biophysics [O. K.], The Norwegian Radium Hospital, and Institute for Cancer Research, Montebello, N-0310; and Department of Urology, Ullevaal Hospital [K. J. T.], Oslo, Norway
Metastatic prostate cancer has an unpredictable long-term prognosis. At present, there are few specific predictors to indicate the outcome for the individual patient. We have studied immunoreactivity for type-2 carbohydrate structures, known to be involved in various cell adhesion processes, in patients with metastatic prostate cancer. One group of patients (n = 26) did not progress within 3 years after orchiectomy, while another group of patients (n = 33) progressed within 1 year following castration and survived less than 2 years. Among the parameters studied, sialyl LewisX carbohydrate up-regulation was the only variable showing significant association with poor prognosis (P < 0.01). Sialyl LewisX discriminated between these two outcome groups with 71% predictability and 96% specificity. Our results indicate that up-regulation of sialyl LewisX is associated with hormonal-resistant, aggressive disease. This prognostic marker may, therefore, have an important role in selecting proper treatment for patients with metastatic prostate cancer.
1 This work was supported by the Norwegian Cancer Society.
2 To whom requests for reprints should be addressed.
Received 2/ 3/95. Accepted 3/20/95.
This article has been cited by other articles:
![]() |
P. Sozzani, R. Arisio, M. Porpiglia, and C. Benedetto Is Sialyl Lewis x Antigen Expression a Prognostic Factor in Patients With Breast Cancer? International Journal of Surgical Pathology, October 1, 2008; 16(4): 365 - 374. [Abstract] [PDF] |
||||
![]() |
S. R Barthel, J. D Gavino, G. K Wiese, J. M Jaynes, J. Siddiqui, and C. J Dimitroff Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin Glycobiology, October 1, 2008; 18(10): 806 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. I. Kawamura, R. Kawashima, R. Fukunaga, K. Hirai, N. Toyama-Sorimachi, M. Tokuhara, T. Shimizu, and T. Dohi Introduction of Sda Carbohydrate Antigen in Gastrointestinal Cancer Cells Eliminates Selectin Ligands and Inhibits Metastasis Cancer Res., July 15, 2005; 65(14): 6220 - 6227. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Dimitroff, M. Lechpammer, D. Long-Woodward, and J. L. Kutok Rolling of Human Bone-Metastatic Prostate Tumor Cells on Human Bone Marrow Endothelium under Shear Flow Is Mediated by E-Selectin Cancer Res., August 1, 2004; 64(15): 5261 - 5269. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mathieu, M. Prorok, A.-M. Benoliel, R. Uch, C. Langlet, P. Bongrand, R. Gerolami, and A. El-Battari Transgene Expression of {alpha}(1,2)-Fucosyltransferase-I (FUT1) in Tumor Cells Selectively Inhibits Sialyl-Lewis x Expression and Binding to E-Selectin without Affecting Synthesis of Sialyl-Lewis a or Binding to P-Selectin Am. J. Pathol., February 1, 2004; 164(2): 371 - 383. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Peracaula, G. Tabares, L. Royle, D. J. Harvey, R. A. Dwek, P. M. Rudd, and R. de Llorens Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins Glycobiology, June 1, 2003; 13(6): 457 - 470. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, M. M. Palcic, H. Mo, I. J. Goldstein, and O. Hindsgaul Rapid determination of the binding affinity and specificity of the mushroom Polyporus squamosus lectin using frontal affinity chromatography coupled to electrospray mass spectrometry Glycobiology, February 1, 2001; 11(2): 141 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Schmauser, C. Kilian, W. Reutter, and R. Tauber Sialoforms of dipeptidylpeptidaseIV from rat kidney and liver Glycobiology, December 1, 1999; 9(12): 1295 - 1305. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. T. Keppler, S. Hinderlich, J. Langner, R. Schwartz-Albiez, W. Reutter, and M. Pawlita UDP-GlcNAc 2-Epimerase: A Regulator of Cell Surface Sialylation Science, May 21, 1999; 284(5418): 1372 - 1376. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |